Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Lurbinectedin in addition to doxorubicin for small-cell lung cancer after prior platinum-containing therapy Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Lurbinectedin (PM01183; Zepzelca) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2020 View  |  Download
Lurbinectedin for platinum resistant ovarian cancer Lurbinectedin (PM01183; Zepzelca) Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer Female Reproductive Cancer 2017 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications